MAPT and Alzheimer disease: Mesenchymal stem cells from umbilical cords, bone marrow, and adipose tissue induced microglial activation and reduced Aβ deposition, tau hyperphosphorylation, and neuroinflammation in AD mouse models, resulting in improved cognitive functioning (161–164).